Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 antiviral treatment relief strategies, in patients co-infected with the HIV-1 and HBV viruses
RecruitingCTIS2023-508634-34-00
Insermco-infected with the HIV-1 and HBV viruses
Start: 2025-05-14Target: 140Updated: 2025-10-20